Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression
Advanced glycation end products (AGEs) are major inflammatory mediators in diabetes, affecting atherosclerosis progression via macrophages. Metformin slows diabetic atherosclerosis progression through mechanisms that remain to be fully elucidated. The present study of murine bone marrow derived macr...
Main Authors: | Zhong’e Zhou, Yong Tang, Xian Jin, Chengjun Chen, Yi Lu, Liang Liu, Chengxing Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2016/4847812 |
Similar Items
-
Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway
by: Xian Jin, et al.
Published: (2015-01-01) -
Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01) -
Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases
by: Alexandra Eichhorst, et al.
Published: (2019-07-01) -
A Bibenzyl Component Moscatilin Mitigates Glycation-Mediated Damages in an SH-SY5Y Cell Model of Neurodegenerative Diseases through AMPK Activation and RAGE/NF-<i>κ</i>B Pathway Suppression
by: Mei Chou Lai, et al.
Published: (2020-10-01) -
The Receptor for Advanced Glycation End Products (RAGE) and the Lung
by: Stephen T. Buckley, et al.
Published: (2010-01-01)